Q1 2021 Navidea Biopharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to Navidea's First Quarter 2021 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Jed Latkin, CEO.
Thank you. This call is being webcast live on our website, and a replay will be made available. Following prepared remarks, we will be conducting a question-and-answer segment. Navidea's Chief Medical Officer, Dr. Mike Rosol; and the company's Vice President of Finance, Erika Eves, will be joining me on the call today. Through the course of this conference call, we will be making forward-looking statements regarding future events and the future performance of the company. These events relate to our business plans to develop Navidea's molecular diagnostics and immunotherapeutics, which include clinical and regulatory developments and timing of clinical data readouts, along with capital resources and strategic matters as well as the impact of the COVID-19 pandemic on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |